The Potential of Neuregulin 4 as a Novel Biomarker and Therapeutic Agent for Vascular Complications in Type 2 Diabetes Mellitus
Xiaofang Dan,1– 3 Ke Li,1– 3 Jiali Xu,4 Pijun Yan1– 3,5,6 1Department of Endocrinology and Metabolism, the Affiliated Hospital of Southwest Medical University, Luzhou, People’s Republic of China; 2Metabolic Vascular Disease Key Laboratory of Sichuan Province, Luzhou, People’s Republic of China; 3Sic...
Saved in:
| Main Authors: | Dan X, Li K, Xu J, Yan P |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2024-11-01
|
| Series: | Journal of Inflammation Research |
| Subjects: | |
| Online Access: | https://www.dovepress.com/the-potential-of-neuregulin-4-as-a-novel-biomarker-and-therapeutic-age-peer-reviewed-fulltext-article-JIR |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The impact of serum neuregulin 4 (NRG-4) levels on non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis
by: Mohammad Amin Tapak, et al.
Published: (2025-07-01) -
Plasma Level’s of Neuregulin-1 in Healthy People
by: K. A. Zhbanov, et al.
Published: (2022-01-01) -
Serum levels of neuregulin-1 in patients with coronary artery disease: clinical and pathogenetic aspects
by: E. A. Zakharyan, et al.
Published: (2024-02-01) -
Neuregulin-1β, Biomarkers of Inflammation and Myocardial Fibrosis in Heart Failure Patients
by: K. A. Zhbanov, et al.
Published: (2022-11-01) -
The Reliability of Serum Neuregulin-4 as a Marker of Polycystic Ovarian Syndrome with Respect to Adiposity Parameters
by: Wassan Nori, et al.
Published: (2023-04-01)